Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Seaspine Holdings Corp (SPNE)  
$9.54 0.00 (0.00%) as of 4:30 Wed 1/4


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 36,440,000
Market Cap: 347.64(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $9.54 - $9.54
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   SeaSpine Holdings is a medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. Co. has a portfolio of orthobiologics and spinal implant solutions, as well as a surgical navigation system to perform fusion procedures in the lumbar, thoracic and cervical spine. Co.'s orthobiologics products consist of a range of bone graft substitutes including spine, hip, and extremities procedures. Co.'s spinal implants portfolio consists of a line of products and image-guided surgical solutions to help spinal fusion in degenerative, minimally invasive surgery, and spinal deformity procedures.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 53,786
Total Sell Value $0 $0 $0 $316,788
Total People Sold 0 0 0 2
Total Sell Transactions 0 0 0 2
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 328
  Page 9 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Valentine Keith Chief Executive Officer   •       •      –    2019-01-01 4 D $18.24 $430,665 D/D (23,611) 224,031     -
   Valentine Keith Chief Executive Officer   •       •      –    2019-01-01 4 OE $0.00 $0 D/D 63,366 247,642     -
   Bostjancic John J. Chief Financial Officer   •       –      –    2019-01-01 4 D $18.24 $185,027 D/D (10,144) 66,694     -
   Bostjancic John J. Chief Financial Officer   •       –      –    2019-01-01 4 OE $0.00 $0 D/D 28,123 76,838     -
   Lipschultz Tyler SVP, Orthobiologics and BD   •       –      –    2019-01-01 4 D $18.24 $85,017 D/D (4,661) 72,973     -
   Lipschultz Tyler SVP, Orthobiologics and BD   •       –      –    2019-01-01 4 OE $0.00 $0 D/D 28,123 77,634     -
   Winge John J. Vice President, Sales   •       –      –    2018-12-31 4 A $6.43 $9,922 D/D 1,544 32,646     -
   Keran Patrick L VP, General Counsel   •       –      –    2018-12-31 4 A $6.43 $7,210 D/D 1,122 26,127     -
   Valentine Keith Chief Executive Officer   •       •      –    2018-12-31 4 A $6.43 $7,750 D/D 1,206 184,276     -
   Lipschultz Tyler SVP, Orthobiologics and BD   •       –      –    2018-12-31 4 A $6.43 $6,722 D/D 1,046 49,511     -
   Bradley Keith Director   –       •      –    2018-11-30 4 D $19.66 $983 D/D (50) 40,908     -
   Bradley Keith Director   –       •      –    2018-08-30 4 D $14.87 $744 D/D (50) 40,958     -
   Henneman John B III Director   –       •      –    2018-08-29 4 S $14.65 $49,913 D/D (3,407) 54,708     -
   Henneman John B III Director   –       •      –    2018-08-28 4 S $14.65 $29,725 D/D (2,029) 58,115     -
   Henneman John B III Director   –       •      –    2018-08-27 4 S $14.72 $67,182 D/D (4,564) 60,144     -
   Essig Stuart Director   –       •      –    2018-08-02 4 S $14.00 $608,944 D/D (43,496) 414,929     -
   Essig Stuart Director   –       •      –    2018-08-02 4 OE $13.60 $591,546 D/D 43,496 458,425     -
   Winge John J. Vice President, Sales   •       –      –    2018-06-29 4 A $6.43 $11,329 D/D 1,763 31,102     -
   Keran Patrick L VP, General Counsel   •       –      –    2018-06-29 4 A $6.43 $14,041 D/D 2,185 25,005     -
   Valentine Keith Chief Executive Officer   •       •      –    2018-06-29 4 A $6.43 $13,501 D/D 2,101 183,070     -
   Lipschultz Tyler SVP, Orthobiologics and BD   •       –      –    2018-06-29 4 A $6.43 $14,529 D/D 2,261 48,465     -
   Bradley Keith Director   –       •      –    2018-06-14 4 D $14.03 $2,399 D/D (171) 41,008     -
   Henneman John B III Director   –       •      –    2018-06-13 4 OE $12.44 $216,431 D/D 17,398 64,708     -
   Blanchard Cheryl R Director   –       •      –    2018-05-30 4 A $0.00 $0 D/D 8,857 28,948     -
   Henneman John B III Director   –       •      –    2018-05-30 4 A $0.00 $0 D/D 13,286 47,310     -
  328 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us